RMD · Resmed Inc
Price
Snapshot
50 fields · last close| Market Cap | $33.06B |
| P/E | 21.74 |
| Float | 144.3M |
| Beta | 0.77 |
| Volatility | 19.3% |
| Exchange | NYSE |
| Sector | Health Care |
| Cap tier | Large cap |
| Macro sensitivity | Moderate |
| Clavix score | 78 |
| Price | 226.84 |
| Change | −1.03% |
| Prev Close | 229.19 |
| Open | 231.20 |
| Day Low | 227.26 |
| Day High | 233.04 |
| Avg Vol | 1 |
| Avg $ Vol | $327.0M |
| 52W High | 284.87 |
| 52W Low | 180.26 |
| 52W Pos | 44.5% |
| From High | −20.37% |
| From Low | +25.84% |
| Max DD 1Y | −35.46% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | −0.89% |
| SMA 50 | +5.66% |
| SMA 200 | −0.71% |
| RSI (14) | 54.3 |
| Vol 30D | 35.6% |
| Vol 90D | 36.5% |
| 1Y Range | 180–285 |
| Daily bars | 506 |
| Perf Week | −2.79% |
| Perf Month | +2.30% |
| Perf Quarter | +17.94% |
| Perf Half Y | −10.23% |
| Perf Year | −14.87% |
| Perf YTD | −7.34% |
| Prev Day | −1.03% |
| Clavix | B+ |
| Debt / Eq | 0.10 |
| Curr Ratio | 3.10 |
| Int Cover | 58.2× |
| FCF Margin | 30.7% |
| Rev Growth | +8.6% |
| Profit | Profitable |
| Leverage | Low |
| Sector rank | 20 / 47 |
What RMD does
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally.
The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution.
The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients’ device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system.
In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers.
ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Clavix risk grade
regraded every trading dayRMD grades B+, 78 of 100. Steadiest on Macro Resilience (69), most exposed on Price Stability (58, mixed). 1 of the 4 weighted dimensions sit above the Health Care median. Ranks 20 of 47 in Health Care by Clavix score.
How rough the ride is
| RMD | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 0.77 | 0.81 |
| Volatilityannualized | 19.3% | 20.4% |
| Max drawdown, past yearworst peak-to-trough fall | −35.5% | — |
| Typical daily movemedian absolute daily change | 1.02% | — |
| Days beyond ±3%of the last 252 sessions | 229% | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| RMD | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 0.77 | 0.81 |
| Macro sensitivityrate, dollar and credit exposure bucket | Moderate | Moderate55% of 47 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| RMD | |
|---|---|
| 1 week | −2.8% |
| 1 month | +2.3% |
| Year to date | −7.3% |
| 1 year | −14.9% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| RMD | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30since 20 Jul |
| Average score0 most bearish, 100 most bullish | 55 |
| Bullish · bearisharticles above 60 · below 40 | 12 · 9 |
| Directionarticles whose tone is improving vs worsening | 12 ↑ 9 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 47 Health Care names Clavix covers; the tick is the sector median.
Growth
| RMD | |
|---|---|
| Revenue growthyear over year | +8.6% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Against Health Care
47 companies| Metric | RMD | Sector spread | Median |
|---|---|---|---|
| Beta | 0.77 | 0.81 | |
| Volatility | 19.3% | 20.4% | |
| P/E | 21.74 | 26.14 | |
| Debt / equity | 0.10 | 0.71 | |
| Current ratio | 3.10 | 1.58 | |
| FCF margin | 30.7% | 8.6% | |
| Interest coverage | 58.2× | 6.3× |
Recent news
most recent scored articles · the chip is the article’s score · click to openResMed entered an agreement with Citibank to buy back $450 million of its own common stock through an accelerated share repurchase. The buyback is being funded by the proceeds from ResMed's sale of its MatrixCare business plus cash on hand.
Westpac Banking Corp disclosed in a regulatory filing that it bought 21,568 shares of ResMed Inc. during the second quarter, opening a new position in the medical equipment provider. The article text is cut off, so additional details such as the dollar value of the stake are not available.
Resmed announced Carol Burt will become Lead Director on November 15, 2026, replacing Ron Taylor, who is retiring after more than 21 years on the board and will not stand for reelection at the November 18, 2026 annual meeting.
Resmed announced Carol Burt will become Lead Director on November 15, 2026, succeeding Ron Taylor, who is retiring after more than 21 years on the board and not standing for reelection at the November 18, 2026 annual meeting.
ResMed reported Q4 fiscal 2026 results on August 6, with quarterly revenue up 9% to $1.5 billion and adjusted profit per share up 16% to $2.95. Full-year revenue grew 10%, free cash flow topped $1.6 billion, and the company raised its dividend 10% to $0.66 per share while planning to return over $1.85 billion to shareholders in fiscal 2027.
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| CNC | Centene Corp | B | $33.60B | — | 1.08 | Compare |
| DXCM | Dexcom Inc | B | $33.85B | 33.86 | 1.45 | Compare |
| VEEV | Veeva Systems Inc | B- | $34.18B | 45.52 | 0.91 | Compare |
| GEHC | GE Healthcare Technologies Inc | B- | $31.49B | 16.79 | 0.82 | Compare |
| ALC | Alcon AG | B+ | $29.66B | 44.75 | 1.12 | Compare |
| LH | Labcorp Holdings Inc | A- | $26.88B | 26.91 | 0.88 | Compare |
| DGX | Quest Diagnostics Inc | A- | $26.42B | 24.97 | 0.56 | Compare |
| IDXX | IDEXX Laboratories Inc | B+ | $41.70B | 36.69 | 1.57 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.